Sorafenib - Wikipedia

Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a kinase inhibitor drug approved for the treatment of primary kidney cancer ...

Sorafenib – Wikipedia

Anwendungsgebiete und Zulassung. Sorafenib zählt zu den Orphan-Arzneimitteln und ist seit 2006 für einige wenige Indikationen in der EU zugelassen.

Sorafenib Uses, Side Effects & Warnings - Drugs.com

Physician reviewed sorafenib patient information - includes sorafenib description, dosage and directions.

Sorafenib (Nexavar) Chemotherapy Drug Information

Sorafenib (Nexavar) tyrosine kinase inhibitor targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of advanced ...

Nexavar (sorafenib) Uses, Dosage, Side Effects - Drugs.com

Nexavar is used to treat advanced renal cell carcinoma. Learn about side effects, interactions and indications.

Sorafénib - VIDAL - La base de données en ligne des ...

Sorafénib : mécanisme d'action, cas d'usage, interactions possibles, prise en charge, médicaments

Sorafenib Prices, Coupons & Savings Tips - GoodRx

Compare prices, print coupons and get savings tips for Sorafenib (Nexavar) and other Renal Cancer and Liver Cancer drugs at CVS, Walgreens, and other pharmacies.

ADVERSE REACTIONS--------------------------

Tablets containing sorafenib tosylate (274 mg) equivalent to 200 mg of sorafenib. NEXAVAR tablets are round, biconvex, red film-coated tablets, debossed with the ...

92-Hepatic advanced sorafenib | eviQ - Cancer Treatments ...

Notes: Overall management should be in consultation with a gastroenterologist. Drug status: Sorafenib is PBS authority. Sorafenib is available as 200 mg tablets.

Trial of TRC105 and Sorafenib in Patients With HCC - Full ...

Sorafenib is an oral multikinase inhibitor targeting several receptor tyrosine kinases, including the VEGF receptor (VEGFR), implicated in pathologic angiogenesis ...